Pfizer Expands API Manufacturing Site in Singapore with $740M+ Investment

1. Investment Amount: Pfizer has invested over $740 million in extending its API (Active Pharmaceutical Ingredient) manufacturing site in Singapore.
2. Facility Expansion: The extension aims to boost Pfizer's API production capabilities at the local plant.
3. Location: The expanded facility is located in Singapore, where Pfizer is further entrenching its roots.
4. Date: The news was announced on July 24, 2024.
5. Source: The information was reported by Endpoints News, a leading source for biotech, drug, pharma, and health news.